JP2007508040A5 - - Google Patents

Download PDF

Info

Publication number: JP2007508040A5
Authority: JP; Japan
Prior art keywords: ray; energy; intensity; detector; pixel
Prior art date: 2004-10-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2006530148A

Other languages

English (en)

Japanese (ja)

Other versions

JP2007508040A (ja

Filing date

2004-10-07

Publication date

2010-07-29

2003-10-10 Priority claimed from DE2003147961 external-priority patent/DE10347961A1/de

2004-10-07 Application filed filed Critical

2007-04-05 Publication of JP2007508040A publication Critical patent/JP2007508040A/ja

2010-07-29 Publication of JP2007508040A5 publication Critical patent/JP2007508040A5/ja

Status Pending legal-status Critical Current

Links

239000002872 contrast media Substances 0.000 claims description 44
238000000034 method Methods 0.000 claims description 42
238000010521 absorption reaction Methods 0.000 claims description 35
238000003384 imaging method Methods 0.000 claims description 24
238000001228 spectrum Methods 0.000 claims description 20
238000001514 detection method Methods 0.000 claims description 10
229910052797 bismuth Inorganic materials 0.000 claims description 8
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 8
230000002596 correlated effect Effects 0.000 claims description 8
229910052794 bromium Inorganic materials 0.000 claims description 7
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
230000015572 biosynthetic process Effects 0.000 claims description 6
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
239000006185 dispersion Substances 0.000 claims description 6
229910052788 barium Inorganic materials 0.000 claims description 5
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 5
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
238000004364 calculation method Methods 0.000 claims description 2
230000001678 irradiating effect Effects 0.000 claims description 2
229910052747 lanthanoid Inorganic materials 0.000 claims 3
150000002602 lanthanoids Chemical class 0.000 claims 3
IOWXSDIECPGQBU-UHFFFAOYSA-M [I-].[Ba+] Chemical compound [I-].[Ba+] IOWXSDIECPGQBU-UHFFFAOYSA-M 0.000 claims 1
229910052740 iodine Inorganic materials 0.000 description 18
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 17
239000011630 iodine Substances 0.000 description 17
238000005259 measurement Methods 0.000 description 17
230000005855 radiation Effects 0.000 description 15
229910052688 Gadolinium Inorganic materials 0.000 description 14
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 13
238000002591 computed tomography Methods 0.000 description 10
238000010586 diagram Methods 0.000 description 9
QWUZMTJBRUASOW-UHFFFAOYSA-N cadmium tellanylidenezinc Chemical compound [Zn].[Cd].[Te] QWUZMTJBRUASOW-UHFFFAOYSA-N 0.000 description 8
239000004065 semiconductor Substances 0.000 description 8
239000007864 aqueous solution Substances 0.000 description 7
125000002346 iodo group Chemical group I* 0.000 description 7
239000002253 acid Substances 0.000 description 6
238000002083 X-ray spectrum Methods 0.000 description 5
210000000481 breast Anatomy 0.000 description 5
230000006870 function Effects 0.000 description 5
230000033001 locomotion Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
238000012545 processing Methods 0.000 description 5
238000002601 radiography Methods 0.000 description 5
241001479434 Agfa Species 0.000 description 4
238000000862 absorption spectrum Methods 0.000 description 4
238000002583 angiography Methods 0.000 description 4
-1 ioprol Chemical compound 0.000 description 4
DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 4
229910052746 lanthanum Inorganic materials 0.000 description 4
230000003902 lesion Effects 0.000 description 4
238000009607 mammography Methods 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
230000003595 spectral effect Effects 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
XUHXFSYUBXNTHU-UHFFFAOYSA-N Iotrolan Chemical compound IC=1C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C=1N(C)C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I XUHXFSYUBXNTHU-UHFFFAOYSA-N 0.000 description 3
230000005540 biological transmission Effects 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
229960001025 iohexol Drugs 0.000 description 3
NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 3
229960003182 iotrolan Drugs 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
210000004872 soft tissue Anatomy 0.000 description 3
229910052692 Dysprosium Inorganic materials 0.000 description 2
UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 2
229910021417 amorphous silicon Inorganic materials 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
150000004696 coordination complex Chemical class 0.000 description 2
239000013078 crystal Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
HZHFFEYYPYZMNU-UHFFFAOYSA-K gadodiamide Chemical compound [Gd+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC HZHFFEYYPYZMNU-UHFFFAOYSA-K 0.000 description 2
150000002251 gadolinium compounds Chemical class 0.000 description 2
GFSTXYOTEVLASN-UHFFFAOYSA-K gadoteric acid Chemical compound [Gd+3].OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 GFSTXYOTEVLASN-UHFFFAOYSA-K 0.000 description 2
DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000007689 inspection Methods 0.000 description 2
229960004359 iodixanol Drugs 0.000 description 2
NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 2
229960004647 iopamidol Drugs 0.000 description 2
XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 2
229960000824 iopentol Drugs 0.000 description 2
IUNJANQVIJDFTQ-UHFFFAOYSA-N iopentol Chemical compound COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I IUNJANQVIJDFTQ-UHFFFAOYSA-N 0.000 description 2
229960002603 iopromide Drugs 0.000 description 2
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical group [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 2
229910052750 molybdenum Inorganic materials 0.000 description 2
229910052703 rhodium Inorganic materials 0.000 description 2
229910052711 selenium Inorganic materials 0.000 description 2
239000011669 selenium Substances 0.000 description 2
238000011410 subtraction method Methods 0.000 description 2
230000005469 synchrotron radiation Effects 0.000 description 2
229910052721 tungsten Inorganic materials 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
OIRFJRBSRORBCM-YFKPBYRVSA-N (2s)-2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid Chemical compound CC[C@H](C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-YFKPBYRVSA-N 0.000 description 1
RISKINCQRSLFRK-UHFFFAOYSA-N 2h-chromene-3-carbaldehyde Chemical compound C1=CC=C2OCC(C=O)=CC2=C1 RISKINCQRSLFRK-UHFFFAOYSA-N 0.000 description 1
230000005461 Bremsstrahlung Effects 0.000 description 1
229910052684 Cerium Inorganic materials 0.000 description 1
229910052691 Erbium Inorganic materials 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
229910052693 Europium Inorganic materials 0.000 description 1
229910052689 Holmium Inorganic materials 0.000 description 1
JXMIBUGMYLQZGO-UHFFFAOYSA-N Iotroxic acid Chemical compound OC(=O)C1=C(I)C=C(I)C(NC(=O)COCCOCCOCC(=O)NC=2C(=C(C(O)=O)C(I)=CC=2I)I)=C1I JXMIBUGMYLQZGO-UHFFFAOYSA-N 0.000 description 1
AMDBBAQNWSUWGN-UHFFFAOYSA-N Ioversol Chemical compound OCCN(C(=O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I AMDBBAQNWSUWGN-UHFFFAOYSA-N 0.000 description 1
229910052765 Lutetium Inorganic materials 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229910052779 Neodymium Inorganic materials 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
229910052777 Praseodymium Inorganic materials 0.000 description 1
IXRDOWODDFSDFO-UHFFFAOYSA-H S(=S)(=O)([O-])[O-].[Gd+3].S(=S)(=O)([O-])[O-].S(=S)(=O)([O-])[O-].[Gd+3] Chemical compound S(=S)(=O)([O-])[O-].[Gd+3].S(=S)(=O)([O-])[O-].S(=S)(=O)([O-])[O-].[Gd+3] IXRDOWODDFSDFO-UHFFFAOYSA-H 0.000 description 1
229910052772 Samarium Inorganic materials 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
229910052771 Terbium Inorganic materials 0.000 description 1
229910052775 Thulium Inorganic materials 0.000 description 1
235000010724 Wisteria floribunda Nutrition 0.000 description 1
229910052769 Ytterbium Inorganic materials 0.000 description 1
MXZROTBGJUUXID-UHFFFAOYSA-I [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 Chemical compound [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 MXZROTBGJUUXID-UHFFFAOYSA-I 0.000 description 1
XALRLIVCVHDVGE-UHFFFAOYSA-N [Te].[Te].[Te].[Gd].[Gd] Chemical compound [Te].[Te].[Te].[Gd].[Gd] XALRLIVCVHDVGE-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012620 biological material Substances 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000037182 bone density Effects 0.000 description 1
230000002308 calcification Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
238000013155 cardiography Methods 0.000 description 1
239000010406 cathode material Substances 0.000 description 1
238000002585 cerebral angiography Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
238000013016 damping Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229960005423 diatrizoate Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical group [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
238000000295 emission spectrum Methods 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
OCDAWJYGVOLXGZ-VPVMAENOSA-K gadobenate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)C(C([O-])=O)COCC1=CC=CC=C1 OCDAWJYGVOLXGZ-VPVMAENOSA-K 0.000 description 1
ZPDFIIGFYAHNSK-UHFFFAOYSA-K gadobutrol Chemical class [Gd+3].OCC(O)C(CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-UHFFFAOYSA-K 0.000 description 1
229960005063 gadodiamide Drugs 0.000 description 1
LGMLJQFQKXPRGA-VPVMAENOSA-K gadopentetate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O LGMLJQFQKXPRGA-VPVMAENOSA-K 0.000 description 1
RYHQMKVRYNEBNJ-BMWGJIJESA-K gadoterate meglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 RYHQMKVRYNEBNJ-BMWGJIJESA-K 0.000 description 1
229960005451 gadoteridol Drugs 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
229960004108 iobitridol Drugs 0.000 description 1
YLPBXIKWXNRACS-UHFFFAOYSA-N iobitridol Chemical compound OCC(O)CN(C)C(=O)C1=C(I)C(NC(=O)C(CO)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I YLPBXIKWXNRACS-UHFFFAOYSA-N 0.000 description 1
OLAOYPRJVHUHCF-UHFFFAOYSA-N iooxitalamic acid Chemical compound CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(C(=O)NCCO)=C1I OLAOYPRJVHUHCF-UHFFFAOYSA-N 0.000 description 1
229950011575 iopronic acid Drugs 0.000 description 1
229960000929 iotalamic acid Drugs 0.000 description 1
229940029378 iothalamate Drugs 0.000 description 1
229960000506 iotroxic acid Drugs 0.000 description 1
229960004537 ioversol Drugs 0.000 description 1
229960003781 ioxitalamic acid Drugs 0.000 description 1
150000002603 lanthanum Chemical class 0.000 description 1
OSFADAHKHPUGSH-UHFFFAOYSA-N lanthanum Chemical compound [La].[La].[La].[La].[La] OSFADAHKHPUGSH-UHFFFAOYSA-N 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
238000002587 lymphangiography Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000005693 optoelectronics Effects 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920006255 plastic film Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
XZNXVSDNACTASG-RZNNTOFGSA-M sodium;3,5-diacetamido-2,4,6-triiodobenzoate;3,5-diacetamido-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol Chemical compound [Na+].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I XZNXVSDNACTASG-RZNNTOFGSA-M 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
229910052714 tellurium Inorganic materials 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000004154 testing of material Methods 0.000 description 1
238000002834 transmittance Methods 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1

JP2006530148A 2003-10-10 2004-10-07 Ｘ線不透過性要素を含む少なくとも１つの被検体での画像形成用のｘ線装置及びｘ線コントラスト方法並びにｘ線装置の使用 Pending JP2007508040A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2003147961 DE10347961A1 (de)	2003-10-10	2003-10-10	Röntgenanordnung und Röntgenkontrastverfahren zur Bildgebung an einem mindestens ein röntgenkontrastgebendes Element enthaltenden Untersuchungsobjekt sowie Verwendung der Röntgenanordnung
PCT/EP2004/011436 WO2005034755A1 (fr)	2003-10-10	2004-10-07	Systeme radiographique et procede de contraste radiographique pour formation d'image sur un objet d'examen contenant au moins un element engendrant un contraste radiographique et utilisation dudit systeme radiographique

Publications (2)

Publication Number	Publication Date
JP2007508040A JP2007508040A (ja)	2007-04-05
JP2007508040A5 true JP2007508040A5 (fr)	2010-07-29

Family

ID=34428426

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2006530148A Pending JP2007508040A (ja)	2003-10-10	2004-10-07	Ｘ線不透過性要素を含む少なくとも１つの被検体での画像形成用のｘ線装置及びｘ線コントラスト方法並びにｘ線装置の使用

Country Status (4)

Country	Link
EP (1)	EP1673012A1 (fr)
JP (1)	JP2007508040A (fr)
DE (1)	DE10347961A1 (fr)
WO (1)	WO2005034755A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005026940A1 (de) *	2005-06-06	2006-12-14	Schering Ag	Röntgenanordnung zur Bilddarstellung eines Untersuchungsobjektes und Verwendung der Röntgenanordnung
DE102005037367B3 (de) *	2005-08-08	2007-04-05	Siemens Ag	Verfahren für eine Röntgeneinrichtung
DE102005052368B4 (de)	2005-10-31	2015-07-30	Bayer Pharma Aktiengesellschaft	Röntgensystem zur Erstellung diagnostischer Röntgendarstellungen unter Applikation von Kontrastmitteln
DE102006040935A1 (de) *	2006-08-31	2008-03-20	Siemens Ag	Vorrichtung und Verfahren zur Aufnahme von Projektionsbildern eines zu untersuchenden Objekts in unterschiedlichen Energiebereichen
JP5355412B2 (ja) *	2006-12-04	2013-11-27	コーニンクレッカフィリップスエヌヴェ	Ｃｔ画像形成システム
JP5105589B2 (ja) *	2007-07-11	2012-12-26	株式会社日立メディコ	Ｘ線ｃｔ装置
RU2508053C2 (ru) *	2008-07-07	2014-02-27	Конинклейке Филипс Электроникс Н.В.	Визуализация к-края
KR101529876B1 (ko) *	2008-10-10	2015-06-19	삼성전자주식회사	영상 처리 장치 및 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3974386A (en) *	1974-07-12	1976-08-10	Wisconsin Alumni Research Foundation	Differential X-ray method and apparatus
DE3517101C1 (de) *	1985-05-11	1986-10-09	Deutsches Elektronen-Synchrotron Desy, 2000 Hamburg	Vorrichtung zur digitalen Subtraktions-Angiographie im Energiesubstraktions-Modus
JPS6395033A (ja) *	1986-10-09	1988-04-26	株式会社日立製作所	分光型放射線画像撮影装置
JP2502555B2 (ja) *	1987-01-09	1996-05-29	松下電器産業株式会社	放射線エネルギ−弁別方法
US5049746A (en) *	1989-10-19	1991-09-17	Fuji Photo Film Co., Ltd.	Method and apparatus for displaying energy subtraction images
JPH04200536A (ja) *	1990-11-30	1992-07-21	Hitachi Ltd	分光型ｘ線画像撮影装置
JPH05346500A (ja) *	1992-06-16	1993-12-27	Sumitomo Electric Ind Ltd	シンクロトロン放射光の波長切換装置
US5434417A (en) *	1993-11-05	1995-07-18	The Regents Of The University Of California	High resolution energy-sensitive digital X-ray
DE10033497B4 (de) *	2000-07-10	2006-09-07	Martin-Luther-Universität Halle-Wittenberg	Röntgenkontrastverfahren zur Erzeugung eines elementselektiven Röntgenkontrastes durch digitale Absorptionskanten-Subtraktion von zwei Kontrastbildern
US6393097B1 (en) *	2000-12-22	2002-05-21	Ge Medical Systems Global Technology Company, Llc	Digital detector method for dual energy imaging
JP2002195961A (ja) *	2000-12-25	2002-07-10	Shimadzu Corp	Ｘ線撮像装置
DE10118792B4 (de) *	2001-04-05	2005-12-22	Schering Ag	Anordnung zur Aufnahme von Projektionsmammogrammen und Verwendung der Anordnung für die Projektionsmammographie
US6816572B2 (en) *	2002-03-08	2004-11-09	Ge Medical Systems Global Technology Co., Llc	Method, system and computer product for processing dual energy images

2003
- 2003-10-10 DE DE2003147961 patent/DE10347961A1/de not_active Ceased
2004
- 2004-10-07 WO PCT/EP2004/011436 patent/WO2005034755A1/fr not_active Ceased
- 2004-10-07 JP JP2006530148A patent/JP2007508040A/ja active Pending
- 2004-10-07 EP EP04790320A patent/EP1673012A1/fr not_active Withdrawn

Publication	Publication Date	Title
CN101203179B (zh)	2011-12-28	用于图形显示受检查对象的x射线装置以及x射线装置的使用
US7672431B2 (en)	2010-03-02	X-ray arrangement and x-ray contrast process for imaging an object under examination that contains at least one radiopaque element as well as use of the x-ray arrangement
US7869569B2 (en)	2011-01-11	System for quantitative radiographic imaging
US7330531B1 (en)	2008-02-12	System for quantitative radiographic imaging
US8000434B2 (en)	2011-08-16	Energy spectrum reconstruction
Haus et al.	2000	Screen-film and digital mammography: image quality and radiation dose considerations
US6714621B2 (en)	2004-03-30	Method and apparatus for radiological examination by injection of a contrast medium
McKinley et al.	2005	Initial study of quasi-monochromatic x-ray beam performance for x-ray computed mammotomography
Cowen	1991	Digital x-ray imaging
US20070025514A1 (en)	2007-02-01	X-ray arrangement for graphic display of an object under examination and use of the x-ray arrangement
JP2007508040A5 (fr)	2010-07-29
JP2007508040A (ja)	2007-04-05	Ｘ線不透過性要素を含む少なくとも１つの被検体での画像形成用のｘ線装置及びｘ線コントラスト方法並びにｘ線装置の使用
Zarei et al.	2022	Evaluation of ultra-low-dose chest CT images to detect lung lesions
Reilly	2019	X‐Ray, CT, and Mammography Technology
Tabakov et al.	2022	Introduction to Diagnostic Radiology (X-Ray and Computed Tomography Imaging)
EP1902677A1 (fr)	2008-03-26	Système de photographie d'image à radiation numérique
Jabri et al.	2004	Management of pediatric radiation dose using GE’s Revolution digital radiography systems
Manchanda et al.	2019	Digital Radiography: An Update
Azhari et al.	2020	X-Ray Imaging and Computed Tomography
Rothenberg	2018	Optimization and Dose Reduction in Mammographic Imaging
Shuaib et al.	2018	Examination Two: Questions
Shuaib et al.	2018	Examination Four: Questions
Luhta	0	John Yorkston
Tanaka et al.	2017	Computed Radiography
Dendy et al.	2003	Special radiographic techniques